康芝药业：控股股东拟协议转让5.0004%公司股份

Group 1 - The controlling shareholder, Hongshi Investment, plans to transfer 5.0004% of its shares in Kangzhi Pharmaceutical to Beijing Chenle Asset Management Co., Ltd. [1] - The share transfer will be executed through a private agreement, with a price of 5.34 yuan per share [1] - The total transaction amount for the share transfer is 122 million yuan [1]